Nanotechnology Assisted Chemotherapy for Targeted Cancer Treatment: Recent Advances and Clinical Perspectives

Author(s): Huan-Rong Lan, Zhi-Qiang Wu, Li-Hua Zhang, Ke-Tao Jin, Shi-Bing Wang*

Journal Name: Current Topics in Medicinal Chemistry

Volume 20 , Issue 27 , 2020

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Nanotechnology has recently provided exciting platforms in the field of anticancer research with promising potentials for improving drug delivery efficacy and treatment outcomes. Nanoparticles (NPs) possess different advantages over the micro and bulk therapeutic agents, including their capability to carry high payloads of drugs, with prolonged half-life, reduced toxicity of the drugs, and increased targeting efficiency. The wide variety of nanovectors, coupled with different conjugation and encapsulation methods available for different theranostic agents provide promising opportunities to fine-tune the pharmacological properties of these agents for more effective cancer treatment methods. This review discusses applications of NPs-assisted chemotherapy in preclinical and clinical settings and recent advances in design and synthesis of different nanocarriers for chemotherapeutic agents. Moreover, physicochemical properties of different nanocarriers, their impacts on different tumor targeting strategies and effective parameters for efficient targeted drug delivery are discussed. Finally, the current approved NPs-assisted chemotherapeutic agents for clinical applications and under different phases of clinical trials are discussed.

Keywords: Nanoparticles, Chemotherapy, Cancer treatment, Radiochemistry, Targeted drug delivery, MDR.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 10 November, 2020
Page: [2442 - 2458]
Pages: 17
DOI: 10.2174/1568026620666200722110808
Price: $65

Article Metrics

PDF: 25